Related references
Note: Only part of the references are listed.Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection
K. Vandenbroeck et al.
GENES AND IMMUNITY (2011)
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis
Sergio E. Baranzini et al.
BRAIN (2010)
IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci
F. Esposito et al.
GENES AND IMMUNITY (2010)
Differential Expression of SOCS1 in Macrophages in Relapsing-Remitting and Chronic EAE and its Role in Disease Severity
Jennifer L. Berard et al.
GLIA (2010)
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility
Rebecca L. Zuvich et al.
HUMAN GENETICS (2010)
IL-22RA2 Associates with Multiple Sclerosis and Macrophage Effector Mechanisms in Experimental Neuroinflammation
Amennai D. Beyeen et al.
JOURNAL OF IMMUNOLOGY (2010)
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1
Amy Strange et al.
NATURE GENETICS (2010)
Multiple sclerosis genetics-is the glass half full, or half empty?
Jorge R. Oksenberg et al.
NATURE REVIEWS NEUROLOGY (2010)
Genome-wide Scan of 500 000 Single-Nucleotide Polymorphisms Among Responders and Nonresponders to Interferon Beta Therapy in Multiple Sclerosis
Manuel Comabella et al.
ARCHIVES OF NEUROLOGY (2009)
Functional SOCS1 polymorphisms are associated with variation in obesity in whites
T. Gylvin et al.
DIABETES OBESITY & METABOLISM (2009)
Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
Maria Ban et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
The expanding genetic overlap between multiple sclerosis and type I diabetes
David R. Booth et al.
GENES AND IMMUNITY (2009)
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
Philip L. De Jager et al.
NATURE GENETICS (2009)
SOCS1 and SOCS3 in the control of CNS immunity
Brandi J. Baker et al.
TRENDS IN IMMUNOLOGY (2009)
Genome-wide pharmacogenomic analysis of the response to interferon β therapy in multiple sclerosis
Esther Byun et al.
ARCHIVES OF NEUROLOGY (2008)
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
Andrew D. Johnson et al.
BIOINFORMATICS (2008)
Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-γ on STAT3 and Smads
Kentaro Tanaka et al.
JOURNAL OF IMMUNOLOGY (2008)
IL7RA polymorphisms and susceptibility to multiple sclerosis
Catherine O'Doherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations
G. Kristjansdottir et al.
JOURNAL OF MEDICAL GENETICS (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis
Frida Lundmark et al.
NATURE GENETICS (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma
Michishige Harada et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
No gene is an island: The flip-flop phenomenon
Ping-I Lin et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Interferon-γ-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis
Roumen Balabanov et al.
JOURNAL OF NEUROSCIENCE (2007)
Differential expression of suppressors of cytokine signaling-1 and-3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis
JL Stark et al.
INTERNATIONAL IMMUNOLOGY (2006)
Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies
AD Skol et al.
NATURE GENETICS (2006)
Glutamate-mediated glial injury:: Mechanisms and clinical importance
C Matute et al.
GLIA (2006)
Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form
MG Mujtaba et al.
JOURNAL OF IMMUNOLOGY (2005)
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
R Srinivasan et al.
BRAIN (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Regulation of signal transducer and activator of transcription and suppressor of cytokine-signaling gene expression in the brain of mice with astrocyte-targeted production of interleukin-12 or experimental autoimmune encephalomyelitis
J Maier et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
